Article
Interaction between HBsAg response and the prognosis of patients with HBV-associated HCC receiving anti-PD-1/PD-L1
2023-12-12
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> :The use of programmed death receptor-1 (PD-1) and programmed death ligand 1 (PD-L1) inhibitors has become widespread in the treatment of advanced hepatocellular carcinoma (HCC). However, the role of hepatitis B virus( HBV) as a major pathogenic factor in HCC has garnered significant attention regarding the efficacy of anti-PD-1/PD-L1 therapy for HBV-related H...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e8c4ceea-7f9e-59d8-b09a-ceff58b604de
- DOI
- 10.21203/rs.3.rs-3710669/v1
